Status:
UNKNOWN
Efficacy of Flunarizine Vs Amitriptyline in Prophylaxis of Migraine Prophylaxis
Lead Sponsor:
Shalamar Institute of Health Sciences
Conditions:
Migraine
Prophylaxis
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
To compare the frequency of acute attack and mean pain score ( assessed by visual analog scale) among subjects using either flunarizine or amitriptyline among patients with migraine coming to tertiary...
Detailed Description
Introduction: Migraine is a genetically influenced complex disorder characterized by episodes of moderate-to-severe headache, most often unilateral and generally associated with nausea and increased ...
Eligibility Criteria
Inclusion
- Age 18- 60 years 2. Both genders 3. 3 or more migraine attacks per month 4. normal systemic and neurological examination 5. not having taken any prophylactic medication for the last 4 months
Exclusion
- Un controlled hypertension 2. Ischemic heart disease, chronic liver failure and chronic liver disease 3. Pregnant patient 4. Known allergies to drug being used in study 5. Major pathology or surgery at the neck or the head 6. Recent injury or road traffic injury at the head or the cervical spine 7. Cancer pain 8. Rheumatological or immune related diseases 9. Implantable metallic or electrical devices in the head 10. Patients using opioids or user of illicit drugs or has had recent history of alcohol or drug abuse.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2024
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT06162819
Start Date
January 1 2024
End Date
September 30 2024
Last Update
December 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shalamar Hospital
Lahore, Punjab Province, Pakistan, 54840